Hastings David C
Trevi Therapeutics, Inc. · Chief Financial Officer
Hastings David C is listed in public filings as officer: Chief Financial Officer. This Hastings David C insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Trevi Therapeutics, Inc. (TRVI), SCYNEXIS, Inc. (SCYX), and Arbutus Biopharma Corporation (ABUS). Investors use Hastings David C's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.2M375k shares | Grant / ExerciseJan 8, 2026 | $4.2M375k shares | $11.21 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --69.2k shares | Grant / ExerciseJun 26, 2025 | Disclosure amount unavailable23k shares | -- | -- | |
| $17k23k shares | Grant / ExerciseJun 26, 2025 | $17.0K23k shares | $0.74 | -- | |
| $1.2M365.8k shares | Grant / ExerciseFeb 14, 2025 | $1.2M365.8k shares | $3.29 | -- | |
| --249.8k shares | Grant / ExerciseFeb 14, 2025 | Disclosure amount unavailable90.1k shares | -- | -- | |
| $524k159.7k shares | SellFeb 4, 2025 | $72.8K22.2k shares | $3.28 | -- | |
| --46.2k shares | Grant / ExerciseJun 20, 2024 | Disclosure amount unavailable23k shares | -- | -- | |
| $43k23k shares | Grant / ExerciseJun 20, 2024 | $43.2K23k shares | $1.88 | -- |